Projects per year
Personal profile
Biography
John joined Alfred Health in October 2014 as the Scientific Director of the Biostatistics Consulting Platform in the Faculty of Medicine, Nursing and Health Sciences Monash University and The Alfred Hospital. From February 2022 he assumed the role of Senior Expert Biostatistician in the Department of Clinical Haematology at The Alfred. He obtained his PhD in Statistics, with a Minor in Genetics, from North Carolina State University (Raleigh). His experience, gained at Peter Mac, Novartis AG and Deakin University, lies mainly in the design and analysis of oncology clinical trials (all phases) but his early-career experience was gained in the design and analysis of experiments in the food and agricultural sciences.
Research interests
Web of Science Researcher ID: https://publons.com/researcher/2658815/john-reynolds/
Google Scholar: https://scholar.google.com.au/citations?hl=en&user=_pHSeSkAAAAJ
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
-
GLAM study - Genomic Liquid biopsy Analysis for Multiple myeloma
Spencer, A., Mithraprabhu, S., Reynolds, J., Wood, E., Wellard, C., Bingham, N., Wong, D., Irving, A., Wright, T., Ho, P. J. & McCaughan, G.
1/08/24 → 31/07/28
Project: Research
-
Establishing blood-based liquid biopsies for early detection of high-risk multiple myeloma
Bingham, N., Mithraprabhu, S., Spencer, A. & Reynolds, J.
1/07/24 → 1/07/25
Project: Research
-
Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management
Mithraprabhu, S., Khong, T., Reynolds, J., Murray, D., Shah, J., Wellard, C., Spencer, A., Ross, J., Perkins, A., Marks, A., Beer, H. & Henderson, M.
1/04/24 → 31/12/26
Project: Research
-
AAT-APP Trial: A RCT of alcohol approach-avoidance training to reduce heavy drinking in people with alcohol use disorders
Manning, V., Verdejo-Garcia, A., Lubman, D., Staiger, P. K., Garfield, J., Reynolds, J., de New, S., Wiers, R. & Roxburgh, A.
1/01/23 → 30/06/26
Project: Research
-
More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial
Spencer, A., Rutherford, C., Reynolds, J., Ho, P. J., McQuilten, Z., Moore, E., King, T., Wood, E., Harrison, S. J. & Irving, A.
Department of Health and Aged Care (Australia)
1/02/22 → 31/01/27
Project: Research
-
Efficacy and Long-Term Outcomes of Eltrombopag Treatment Within 6 Months of Diagnosis in Patients With Steroid Unresponsive or Dependent Immune Thrombocytopenia
Tran, H., Dix, C., Bird, R., Chunilal, S., Brighton, T., Reynolds, J., He, S., Mazis, C. & Grigg, A., Mar 2025, In: American Journal of Hematology. 100, 3, p. 516-519 4 p.Research output: Contribution to journal › Letter › Research › peer-review
Open Access -
Asciminib monotherapy as frontline treatment of chronic phase chronic myeloid leukemia: results from the ASCEND study
Yeung, D. T., Shanmuganathan, N., Reynolds, J., Branford, S., Walia, M., Yong, A. S. M., Shortt, J., Chee, L., Viiala, N., Cunningham, I., Ross, D. M., D'Souza, A., Wright, M., Harrup, R., Forsyth, C., Filshie, R., Lane, S., Browett, P., Grove, C., Grigg, A., & 2 others , 7 Nov 2024, In: Blood. 144, 19, p. 1993–2001 25 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients
Mithraprabhu, S., Reynolds, J., Quach, H., Horvath, N., Kerridge, I., Khong, T., Durie, B. G. M. & Spencer, A., Mar 2024, In: Haematologica. 109, 3, p. 974-978 5 p.Research output: Contribution to journal › Letter › Research › peer-review
Open Access2 Citations (Scopus) -
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
Mollee, P., Reynolds, J., Janowski, W., Quach, H., Campbell, P., Gibbs, S., Lee, S., Lee, E., Taylor, K., Cochrane, T., Wallington-Gates, C., Kwok, F., Weber, N., Kerridge, I., Weston, H., Ho, P. J., Leahy, M. F., Horvath, N. & Spencer, A., 23 Jul 2024, In: Blood Advances. 8, 14, p. 3721-3730 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
de Albornoz, S. C., Higgins, A. M., Petrie, D., Irving, A., Fanning, L., Weinkove, R., Crispin, P., Dendle, C., Gilbertson, M., Johnston, A., Keegan, A., Pepperell, D., Pullon, H., Reynolds, J., van Tonder, T., Trotman, J., Waters, N., Wellard, C., Weston, H., Morrissey, C. O., & 2 others , 14 May 2024, In: Blood Advances. 8, 9, p. 2259-2267 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)
Activities
-
American Society of Hematology, Clinical Research Training Institute 2025
John Reynolds (Invited speaker)
18 Feb 2025 → 21 Feb 2025Activity: Participating in or organising an event types › Contribution to conference
-
American Society of Hematology, Clinical Research Training Institute 2024
John Reynolds (Invited speaker)
13 Feb 2024 → 14 Feb 2024Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
CML Opinion Leader Training
John Reynolds (Invited speaker)
7 Sept 2023 → 8 Sept 2023Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
American Society of Hematology, Clinical Research Training Institute 2023
John Reynolds (Invited speaker)
7 Mar 2023 → 9 Mar 2023Activity: Participating in or organising an event types › Contribution to workshop, seminar, course
-
iCMLf - CML Preceptorship 2019
John Reynolds (Invited speaker)
5 Sept 2019 → 6 Sept 2019Activity: Participating in or organising an event types › Contribution to workshop, seminar, course